Dissecting the Signaling Pathways Involved in the Crosstalk between Metabotropic Glutamate 5 and Cannabinoid Type 1 Receptors
Author(s) -
Isabella G. Olmo,
Talita H. FerreiraVieira,
Fabíola M. Ribeiro
Publication year - 2016
Publication title -
molecular pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.469
H-Index - 198
eISSN - 1521-0111
pISSN - 0026-895X
DOI - 10.1124/mol.116.104372
Subject(s) - metabotropic glutamate receptor , metabotropic glutamate receptor 7 , neuroscience , metabotropic glutamate receptor 5 , class c gpcr , glutamatergic , metabotropic glutamate receptor 2 , metabotropic glutamate receptor 1 , crosstalk , metabotropic glutamate receptor 6 , metabotropic receptor , metabotropic glutamate receptor 8 , cannabinoid , excitatory postsynaptic potential , inhibitory postsynaptic potential , endocannabinoid system , glutamate receptor , chemistry , biology , receptor , biochemistry , physics , optics
The metabotropic glutamate 5 receptor and the cannabinoid type 1 receptor are G protein-coupled receptors that are widely expressed in the central nervous system. Metabotropic glutamate 5 receptors, present at the postsynaptic site, are coupled to Gα q/11 proteins and display an excitatory response upon activation, whereas the cannabinoid type 1 receptor, mainly present at presynaptic terminals, is coupled to the G i/o protein and triggers an inhibitory response. Recent studies suggest that the glutamatergic and endocannabinoid systems exhibit a functional interaction to modulate several neural processes. In this review, we discuss possible mechanisms involved in this crosstalk and its relationship with physiologic and pathologic conditions, including nociception, addiction, and fragile X syndrome.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom